The pharmaceutical industry exports in Sweden have shown a notable upward trend over the past decade. Between 2013 and 2023, the value of exports has generally increased from $8.58 billion to $12.11 billion, reflecting a significant growth trajectory despite some fluctuations. In particular, there were substantial year-on-year increases in 2018 (10.29%) and 2019 (18%), although there were occasional declines, most notably in 2021 (-6.49%).
The compound annual growth rate (CAGR) over the past five years stands at 5.29%, indicating solid long-term growth. For 2023, the value reached $12.11 billion, with a year-on-year increase of 2.01%. Future forecasts predict continued growth, with a forecasted CAGR of 1.43% over the next five years.
Future trends to watch for:
- Global economic conditions and their impact on pharmaceutical demand.
- Regulatory changes in key export markets.
- Innovations in pharmaceutical products driving new demand.
- Geopolitical factors affecting trade relationships.
